Cargando…
Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer
Background: Therapy-related neuroendocrine prostate cancer (NEPC) is a lethal castration-resistant prostate cancer (CRPC) subtype that, at present, lacks well-characterized molecular biomarkers. The clinical diagnosis of this disease is dependent on biopsy and histological assessment: methods that a...
Autores principales: | Zhang, Cuijian, Qian, Jinqin, Wu, Yucai, Zhu, Zhenpeng, Yu, Wei, Gong, Yanqing, Li, Xuesong, He, Zhisong, Zhou, Liqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503838/ https://www.ncbi.nlm.nih.gov/pubmed/34646089 http://dx.doi.org/10.3389/pore.2021.1609968 |
Ejemplares similares
-
Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy
por: Zhang, Cuijian, et al.
Publicado: (2022) -
The Ion Channel-Related Gene Signatures Correlated With Diagnosis, Prognosis, and Individualized Treatment in Patients With Clear Cell Renal Cell Carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2022) -
Pulmonary Large Cell Neuroendocrine Carcinoma
por: Yang, Lan, et al.
Publicado: (2022) -
Pulmonary Combined Large Cell Neuroendocrine Carcinoma
por: Li, Meihui, et al.
Publicado: (2022) -
Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features
por: Turkevi-Nagy, Sándor, et al.
Publicado: (2021)